Aaron D. Tward

11.3k total citations
40 papers, 3.4k citations indexed

About

Aaron D. Tward is a scholar working on Molecular Biology, Clinical Biochemistry and Otorhinolaryngology. According to data from OpenAlex, Aaron D. Tward has authored 40 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Clinical Biochemistry and 6 papers in Otorhinolaryngology. Recurrent topics in Aaron D. Tward's work include Paraoxonase enzyme and polymorphisms (7 papers), Ear Surgery and Otitis Media (5 papers) and Single-cell and spatial transcriptomics (4 papers). Aaron D. Tward is often cited by papers focused on Paraoxonase enzyme and polymorphisms (7 papers), Ear Surgery and Otitis Media (5 papers) and Single-cell and spatial transcriptomics (4 papers). Aaron D. Tward collaborates with scholars based in United States, United Kingdom and Germany. Aaron D. Tward's co-authors include Diana M. Shih, Aldons J. Lusis, Andrei Goga, J. Michael Bishop, Patrick Concannon, Richard A. Gatti, Dun Yang, David O. Morgan, Julie B. Sneddon and Lucio G. Costa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.

In The Last Decade

Aaron D. Tward

38 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron D. Tward United States 23 1.6k 762 640 631 471 40 3.4k
Peter S. Choi United States 27 2.4k 1.5× 400 0.5× 162 0.3× 316 0.5× 121 0.3× 45 4.3k
Yasunori Fujita Japan 34 2.0k 1.3× 1.1k 1.4× 162 0.3× 335 0.5× 80 0.2× 105 3.8k
David Meierhofer Germany 30 1.8k 1.1× 445 0.6× 179 0.3× 155 0.2× 102 0.2× 84 2.9k
Tayebeh Pourmotabbed United States 28 635 0.4× 702 0.9× 170 0.3× 452 0.7× 107 0.2× 79 2.2k
Thomas Gelehrter United States 39 2.3k 1.4× 1.6k 2.2× 296 0.5× 427 0.7× 92 0.2× 106 4.7k
Chih‐Chuan Liang China 25 1.4k 0.9× 407 0.5× 205 0.3× 146 0.2× 167 0.4× 100 2.7k
Jeffrey I. Kreisberg United States 42 3.2k 2.0× 694 0.9× 417 0.7× 852 1.4× 62 0.1× 103 5.9k
Susumu Ohwada Japan 35 2.0k 1.2× 404 0.5× 149 0.2× 1.1k 1.7× 97 0.2× 259 4.5k
Shaolin Shi China 31 2.0k 1.3× 502 0.7× 135 0.2× 178 0.3× 77 0.2× 70 3.1k
Xin Pan China 27 2.3k 1.4× 722 0.9× 171 0.3× 284 0.5× 56 0.1× 71 3.0k

Countries citing papers authored by Aaron D. Tward

Since Specialization
Citations

This map shows the geographic impact of Aaron D. Tward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron D. Tward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron D. Tward more than expected).

Fields of papers citing papers by Aaron D. Tward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron D. Tward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron D. Tward. The network helps show where Aaron D. Tward may publish in the future.

Co-authorship network of co-authors of Aaron D. Tward

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron D. Tward. A scholar is included among the top collaborators of Aaron D. Tward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron D. Tward. Aaron D. Tward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scaria, Sonia M., Stacey M. Frumm, Amar H. Sheth, et al.. (2023). Epimorphic regeneration in the mammalian tympanic membrane. npj Regenerative Medicine. 8(1). 58–58. 3 indexed citations
2.
Scaria, Sonia M. & Aaron D. Tward. (2022). Endoscopic Medial Reepithelization for Inflammatory Canal Stenosis. Otology & Neurotology. 43(8). 973–977. 1 indexed citations
3.
Dahlgren, Madelene W., Stephen W. Jones, Kelly M. Cautivo, et al.. (2019). Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches. Immunity. 50(3). 707–722.e6. 232 indexed citations
4.
Marsh, Timothy, et al.. (2019). Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. eLife. 8. 51 indexed citations
5.
Molofsky, Ari B., Madelene W. Dahlgren, Stephen W. Jones, et al.. (2019). Adventitial stromal cells define group 2 innate lymphoid cell tissue niches. The Journal of Immunology. 202(1_Supplement). 129.1–129.1. 1 indexed citations
6.
Emmerson, Elaine, Alison J. May, Noel Cruz‐Pacheco, et al.. (2018). Salivary glands regenerate after radiation injury through SOX2‐mediated secretory cell replacement. EMBO Molecular Medicine. 10(3). 94 indexed citations
7.
Byrnes, Lauren, Daniel Wong, Meena Subramaniam, et al.. (2018). Lineage dynamics of murine pancreatic development at single-cell resolution. Nature Communications. 9(1). 3922–3922. 123 indexed citations
8.
Breshears, Jonathan D., Joseph Chang, Annette M. Molinaro, et al.. (2018). Duration and Timing of Transient Tumor Enlargement after Gamma Knife Radiosurgery for Vestibular Schwannomas. Journal of Neurological Surgery Part B Skull Base. 79(S 01). S1–S188.
9.
Farmer, D’Juan T., Sara Nathan, Kevin Shengyang Yu, et al.. (2017). Defining epithelial cell dynamics and lineage relationships in the developing lacrimal gland. Development. 144(13). 2517–2528. 46 indexed citations
10.
Camarda, Roman, Alicia Y. Zhou, Rebecca A. Kohnz, et al.. (2016). Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nature Medicine. 22(4). 427–432. 396 indexed citations
11.
Li, Jinyu, Maïa Chanrion, Eric T. Sawey, et al.. (2015). Reciprocal Interaction of Wnt and RXR-α Pathways in Hepatocyte Development and Hepatocellular Carcinoma. PLoS ONE. 10(3). e0118480–e0118480. 12 indexed citations
12.
Tward, Aaron D., Kirk D. Jones, Stephen R. Yant, et al.. (2007). Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proceedings of the National Academy of Sciences. 104(37). 14771–14776. 164 indexed citations
13.
Goga, Andrei, Dun Yang, Aaron D. Tward, David O. Morgan, & J. Michael Bishop. (2007). Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nature Medicine. 13(7). 820–827. 261 indexed citations
14.
Sheth, Sonal S., Jackie Bodnar, Anatole Ghazalpour, et al.. (2006). Hepatocellular carcinoma in Txnip-deficient mice. Oncogene. 25(25). 3528–3536. 126 indexed citations
15.
Furlong, Clement E., Toby B. Cole, Diana M. Shih, et al.. (2005). Paraoxonase 1 (PON1) status and risk of insecticide exposure. Journal of Biochemical and Molecular Toxicology. 19(3). 182–183. 10 indexed citations
16.
Tward, Aaron D., et al.. (2005). Genomic Progression in Mouse Models for Liver Tumors. Cold Spring Harbor Symposia on Quantitative Biology. 70(1). 217–224. 12 indexed citations
17.
Cole, Toby B., Diana M. Shih, Aaron D. Tward, et al.. (2005). Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenetics and Genomics. 15(8). 589–598. 79 indexed citations
18.
Furlong, Clement E., Toby B. Cole, Gail P. Jarvik, et al.. (2004). Role of Paraoxonase (PON1) Status in Pesticide Sensitivity: Genetic and Temporal Determinants. NeuroToxicology. 26(4). 651–659. 64 indexed citations
19.
Araujo, Jesús A., Lingzhong Meng, Aaron D. Tward, et al.. (2003). Systemic Rather Than Local Heme Oxygenase-1 Overexpression Improves Cardiac Allograft Outcomes in a New Transgenic Mouse. The Journal of Immunology. 171(3). 1572–1580. 73 indexed citations
20.
Li, Wan-Fen, Lucio G. Costa, Rebecca J. Richter, et al.. (2000). Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics. 10(9). 767–779. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter S. Choi Breakdown of academic impact, for papers by Yasunori Fujita Breakdown of academic impact, for papers by David Meierhofer Breakdown of academic impact, for papers by Tayebeh Pourmotabbed Breakdown of academic impact, for papers by Thomas Gelehrter Breakdown of academic impact, for papers by Chih‐Chuan Liang Breakdown of academic impact, for papers by Jeffrey I. Kreisberg Breakdown of academic impact, for papers by Susumu Ohwada Breakdown of academic impact, for papers by Shaolin Shi Breakdown of academic impact, for papers by Xin Pan
Rankless by CCL
2026